Lv1
60 积分 2026-02-02 加入
Nano‐Enabled Systemic Delivery of STING Agonist by Engineered Silicasome for Potent Antitumor Immunotherapy
20天前
已完结
Q-Factor Optimization of Modes in Ordered and Disordered Photonic Systems Using Non-Hermitian Perturbation Theory
28天前
已完结
Near-Field Imaging of Magnetic Complex Mode Volume
28天前
已完结
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
1个月前
已完结
Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder Cancer
1个月前
已关闭
Neoadjuvant and adjuvant enfortumab vedotin (EV) plus pembrolizumab (pembro) for participants with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin: Randomized, open-label, phase 3 KEYNOTE-B15 study
1个月前
已关闭
Bladder cuff excision at radical nephroureterectomy improved survival in upper tract urothelial carcinoma
1个月前
已关闭
Bladder cuff excision at radical nephroureterectomy improved survival in upper tract urothelial carcinoma
1个月前
已关闭
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
1个月前
已完结
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
1个月前
已完结
皖公网安备34019202002308
